Glivec News
Most Popular Glivec Story
Novartis backs out of India R&D deal
Too bad, India. Novartis CEO Daniel Vasella says he's scrapping plans to invest millions in R&D there. The reason? Intellectual property protections aren't adequate in India, Vasella says. Of Read more...
Latest Headlines
- December 6, 2011
- December 6, 2010
- September 16, 2010
- December 8, 2009
- July 6, 2009
- April 15, 2009
- December 10, 2007
- September 4, 2007
- August 22, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
